Marvell Stock Falls Despite Wave of $400 Price Target Hikes

Marvell Technology just got one of the biggest waves of price-target hikes of the year, and the stock still fell on the news. That contradiction tells you where Wall Street's head is at on this chip name right now.

The trigger was Marvell's October 6 Investor Day, where management laid out ambitious long-term targets: fiscal 2031 revenue of $70 billion to $90 billion, a huge jump from current levels. BofA, Needham and Piper Sandler's David O'Connor all raised price targets to $400, as 247 Wall St. reported. TD Cowen went further, upgrading the stock to Buy outright with a $350 target and pointing to potential EPS north of $30 within three years.

Here's the catch: the stock trades around $281, down roughly 2% the morning after the event, following a 231% year-to-date run. Current-quarter guidance calls for revenue of $3.15 billion, give or take 5%, and that's the number bulls need to see cleared at the next earnings report.

Four product lines are driving the long-term story: custom AI silicon, built for a single customer's design such as AI accelerators for Google; the support chips that surround those processors; and interconnect technology linking AI systems together inside and across data centers. Marvell already pulls 79% of its revenue from data centers, making this a concentrated bet on AI infrastructure spending staying hot for years, according to MarketBeat's coverage of the stock.

"Management don't know that they needed to raise the bar this high." — Joseph Moore, Analyst, Morgan Stanley

That quote captures the tension in one line. Morgan Stanley raised its own target too, but kept a Neutral rating, arguing the new numbers sit at least 20% above old projections and may be more aspiration than near-term reality. Goldman Sachs is even more skeptical — its $270 target actually sits below where the stock trades today.

For investors who already own MRVL, the Investor Day targets are a reason to stay patient rather than a reason to chase the stock here. At roughly 62 times forward earnings and a beta of 2.26, this name swings hard in both directions — a single disappointing quarter could hit it far harder than the broader market.

If you're looking for an entry point rather than already holding, the next earnings report is the real test, not the Investor Day slides. A quarter that hits or beats the $3.15 billion revenue midpoint, with the custom-chip ramp showing up in the results, would support the bull case and could be a better signal to add than buying into the post-event excitement.

The counterargument is worth taking seriously. Every one of these new targets assumes AI infrastructure spending keeps compounding for roughly half a decade. If hyperscalers pull back capital spending even modestly, a stock priced for perfection at 62x earnings has a lot further to fall than a cheaper name would. A debt-fueled AI capex cycle elsewhere in the market adds another wrinkle: if financing costs for hyperscalers rise alongside Treasury yields, capital spending plans could slow sooner than any of these Wall Street models assume.

Customer concentration is a related risk worth tracking. Marvell's growth is tied closely to a small number of large AI customers, and any shift in their spending plans moves the stock disproportionately — in either direction.

Insider activity adds a small note of caution too. Marvell's COO and CEO both sold shares in recent months under pre-arranged trading plans, a normal practice but not exactly a bullish signal on its own.

Bottom line: Marvell's long-term AI story is real, but with Wall Street itself split on whether the new targets are achievable, this is a name to watch into the next earnings report rather than one to buy purely on Investor Day hype.